The EBMT activity survey: 1990–2010
Jakob Passweg(University Hospital of Basel), Carmen Ruiz de Elvira(Felix Platter-Hospital), Christina Peters(Cancer Research Institute of the Slovak Academy of Sciences), J. Alejandro Madrigal(Royal Free London NHS Foundation Trust), Helen Baldomero(University Hospital of Basel), Simone Cesaro(Azienda Ospedaliera Universitaria Integrata Verona), Mohamad Mohty(Sorbonne Université), Balan Louis Gaspar, Andrea Velardi(University Niccolò Cusano), Aloïs Gratwohl, Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Marco Bregni(Ospedale San Giuseppe), Peter Dreger(Heidelberg University), André Tichelli(University Hospital of Basel), T. de Witte(Radboud University Nijmegen), Judith Marsh(King's College London), Dominique Farge(Hôpital Saint-Louis), F. Falkenburg(Dutch Cancer Society)
Cited by 193
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
|New England Journal of Medicine|2009|1k
Solid Cancers after Bone Marrow Transplantation
|New England Journal of Medicine|1997|968
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
|New England Journal of Medicine|2020|859